SMS Lifesciences

SMSLIFE29 Apr 2024

Pharmaceuticals

₹

+33.50 (+4.98%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in SMS Lifesciences

SMS Lifesciences

Pharmaceuticals

SMSLIFE29 Apr 2024

₹

+33.50 (+4.98%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
29-May-2023	D	Board Meeting Outcome for Outcome Of 85Th Board Meeting (29.05.2023) Board of Directors has recommended a dividend of ?1.50/- (15%) per equity share of ?10/- face value, for the year 2022-23, subject to the approval of the Shareholders.	22-Sep-2023
28-May-2022	D	SMS Lifesciences India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2022, inter alia, has recommended a dividend of Rs. 1.50/- (15%) per equity share Rs. 10/- face value, for the year 2021-22, subject to the approval of the Shareholders at the ensuing 16th Annual General Meeting (AGM) of the Company.	22-Sep-2022
18-Jun-2021	D	SMS Lifesciences India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 18, 2021, inter alia, have recommended a dividend of Rs. 1.50/- (15%) per equity share of Rs. 10 face value for the Financial year 2020-21. The dividend will be paid on or after five days from the date of approval by the shareholders at the 15th Annual General Meeting (AGM).	20-Sep-2021
29-May-2019	D	Recommended a dividend of Rs.1.50 (15 %) per equity share of Rs.lO / - (Rupees ten) each (face value), for the financial year ended 31 st March, 2019. The dividend will be paid subject to the approval of the shareholders at the ensuing Annual General Meeting.	19-Sep-2019
25-Apr-2024	BC	Suresh Babu Potluri (Sale Dated on: 01/04/2024 to 19/04/2024)	01-Apr-2024
15-Dec-2023	BC	Source: BSE Announcement PDF The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 25, 20	25-Mar-2024
20-Dec-2023	BC	Source: BSE Announcement PDF The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 25, 20	25-Mar-2024
03-Feb-2024	BC	SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve 1. Unaudited financial results (Stan	10-Feb-2024
30-Dec-2023	BC	TV Praveen	28-Dec-2023

No Rights has been declared by SMSLIFE

Book Closure

Record Date	Split Date	Purpose
01-Apr-2024	-	Suresh Babu Potluri (Sale Dated on: 01/04/2024 to 19/04/2024)
25-Mar-2024	01 Jan'1900	Source: BSE Announcement PDF The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 25, 20
25-Mar-2024	01 Jan'1900	Source: BSE Announcement PDF The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 25, 20
10-Feb-2024	-	SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve 1. Unaudited financial results (Stan
28-Dec-2023	-	TV Praveen

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
SMS Lifesciences India Ltd ₹705.85(+33.50/4.98%)	705.85	+33.50	203.27	23.27	23.32	1.21
Astrazeneca Pharma India Ltd ₹5,556.10(+140.70/2.60%)	5,556.10	+140.70	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹124.45(+1.85/1.51%)	124.45	+1.85	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,407.55(-1.85/-0.13%)	1,407.55	-1.85	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹26,277.60(+412.75/1.60%)	26,277.60	+412.75	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹709.40(+28.55/4.19%)	709.40	+28.55	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	71.23	67.84	74.56	65.55	90.76	78.48
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	71.23	67.84	74.56	65.55	90.76	78.48
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.64	0.33	0.58	4.64	0.50	0.13
Total Income	71.87	68.18	75.14	70.19	91.26	78.61
Total Expenditure	62.21	58.37	69.44	63.03	82.55	72.04
PBIDT	9.66	9.81	5.71	7.16	8.71	6.57
Interest	2.04	2.48	1.82	1.41	1.26	1.24
PBDT	7.62	7.33	3.89	5.75	7.45	5.33
Depreciation	2.55	2.55	2.53	2.12	2.03	2.04
Tax	1.50	1.40	0.40	-1.10	1.50	0.75
Deferred Tax	0.26	0.26	0.26	2.26	-0.09	-0.09
Reported Profit After Tax	3.31	3.12	0.70	2.47	4.01	2.63
Extra-ordinary Items	0.00	0.00	0.00	0.89	0.00	0.00
Adjusted Profit After Extra-ordinary item	3.31	3.12	0.70	1.58	4.01	2.63

EPS (Unit Curr.)	10.96	10.31	2.32	8.17	13.26	8.71
EPS (Adj) (Unit Curr.)	10.96	10.31	2.32	8.17	13.26	8.71
Calculated EPS (Unit Curr.)	10.96	10.31	2.32	8.17	13.26	8.71
Calculated EPS (Adj) (Unit Curr.)	10.96	10.31	2.32	8.17	13.26	8.71
Calculated EPS (Ann.) (Unit Curr.)	43.85	41.24	9.27	32.67	53.06	34.83
Calculated EPS (Adj) (Ann.) (Unit Curr.)	43.85	41.24	9.27	32.67	53.06	34.83
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	3.02	3.02	3.02	3.02	3.02	3.02
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	13.56	14.46	7.66	10.92	9.60	8.37
PBDTM(%)	10.70	10.80	5.22	8.77	8.21	6.79
PATM(%)	4.65	4.60	0.94	3.77	4.42	3.35

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	72.05	69.26	74.65	63.73	88.29	81.26
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	72.05	69.26	74.65	63.73	88.29	81.26
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.58	0.27	0.61	4.81	0.49	0.15
Total Income	72.64	69.53	75.27	68.54	88.78	81.41
Total Expenditure	62.76	61.33	72.12	61.45	78.92	72.99
PBIDT	9.87	8.20	3.14	7.09	9.87	8.42
Interest	2.34	2.81	2.18	1.80	1.67	1.68
PBDT	7.54	5.39	0.97	5.29	8.19	6.74
Depreciation	3.73	3.73	3.70	2.92	2.63	2.64
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	1.50	1.40	0.40	-1.10	1.50	0.75
Deferred Tax	-1.81	0.70	0.70	1.35	0.24	0.22
Reported Profit After Tax	4.12	-0.44	-3.83	2.11	3.82	3.12
Minority Interest After NP	-0.18	-1.12	-2.03	0.40	-0.17	0.37
Net Profit after Minority Interest	4.30	0.68	-1.80	1.71	3.99	2.75

Extra-ordinary Items	0.00	0.00	0.00	1.01	0.00	0.00
Adjusted Profit After Extra-ordinary item	4.30	0.68	-1.80	0.70	3.99	2.75

EPS (Unit Curr.)	14.24	2.20	-5.94	5.66	13.18	9.10
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	3.02	3.02	3.02	3.02	3.02	3.02

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	13.70	11.84	4.21	11.13	11.18	10.36
PBDTM(%)	10.46	7.78	1.30	8.30	9.28	8.29
PATM(%)	5.72	-0.64	-5.13	3.31	4.33	3.84

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	3.02	3.02	3.02	3.02	3.02	3.02
Reserves Total	161.00	148.19	123.31	110.23	101.96	85.38
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	164.02	151.21	126.33	113.25	104.98	88.40
Secured Loans	81.54	54.79	39.43	43.77	41.02	21.28
Unsecured Loans	5.45	7.28	5.43	6.32	6.08	6.08
Total Debt	86.99	62.07	44.86	50.09	47.10	27.36
Total Liabilities	251.01	213.28	171.19	163.34	152.08	115.76
APPLICATION OF FUNDS :
Gross Block	176.07	128.16	131.29	118.16	105.11	80.54
Less : Accumulated Depreciation	36.46	29.44	30.46	23.67	17.07	11.36
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	139.61	98.72	100.83	94.49	88.04	69.18
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.85	21.21	3.16	2.47	1.31	7.09
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	23.23	23.24	25.81	25.81	25.81	5.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	80.46	81.36	58.76	61.05	73.87	49.32
Sundry Debtors	45.52	33.77	29.99	22.02	36.58	27.08
Cash and Bank	0.95	2.14	8.90	2.30	2.47	0.76
Loans and Advances	40.66	45.05	37.77	15.84	16.62	11.57
Total Current Assets	167.60	162.32	135.42	101.21	129.54	88.72
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	69.56	83.32	80.10	53.02	87.65	50.78
Provisions	1.28	2.26	1.67	1.26	0.60	0.94
Total Current Liabilities	70.85	85.58	81.77	54.28	88.25	51.73
Net Current Assets	96.75	76.74	53.66	46.93	41.29	36.99
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	3.69	3.66	2.77	1.04	0.91	0.80
Deferred Tax Liability	15.59	13.54	12.62	9.78	8.89	7.97
Net Deferred Tax	-11.90	-9.88	-9.85	-8.74	-7.98	-7.17
Total Assets	248.55	210.03	173.61	160.96	148.48	111.09
Contingent Liabilities	16.32	21.42	25.11	20.00	4.01	3.61

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.95	8.46	0.65	2.03	0.44
Net Cash from Operating Activities	4.58	-14.66	21.62	13.95	27.26
Net Cash Used In Investing Activities	-27.96	-7.49	-5.94	-13.28	-43.27
Net Cash Used In Financing Activities	22.59	14.63	-7.87	-2.05	17.60
Net Inc./Dec In Cash And Cash Equivalents	-0.80	-7.52	7.81	-1.38	1.60
Cash And Cash Equivalents At End Of The Year	0.15	0.95	8.46	0.65	2.03

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

71.19%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

28.81%

**Promoter pledged shareholding 71.19%

About SMS Lifesciences India Ltd

SMS Lifesciences India Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 203.27 crores. It has reported a sales of Rs. 71.23 crores and a net profit of Rs. 3.31 crores for the quarter ended December 2018. The company management includes , T V V S N Murthy,P Sarath Kumar,Trupti Ranjan Mohanty,Talluri Venkata Praveen,Sudeepthi Gopin eedi,Mannam Malakondaiah,Srinivas Samavedam,P Venkata Subbarao (SMS Lifesciences India Ltd) among others.

Chairman

Registered office

Plot No 19-III Road No 71,Opp Bharatiya Vidya Bhavan PSc,Hyderabad,Telangana,500096

FAX :91-040-2355-1401

Background

Incorporation Year2006

Face Value₹10

Market Lot1

How to buy SMS Lifesciences shares on nse?

To buy SMS Lifesciences shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the SMS Lifesciences share price today?

The SMS Lifesciences shares price on nse is Rs.705.85 today.

What is the market cap of SMS Lifesciences shares on BSE ?

The company has a market capitalization of Rs.203.27Cr

What is the PE & PB ratio of SMS Lifesciences shares ?

PE is 23.32 and PB is 1.21

What is the 52 Week High and Low of SMS Lifesciences shares?

SMS Lifesciences stock price high: Rs.779 SMS Lifesciences stock price low: Rs.464.05